HBK Investments L P acquired a new stake in Imperva Inc (NASDAQ:IMPV) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 29,500 shares of the software maker’s stock, valued at approximately $1,171,000. HBK Investments L P owned about 0.09% of Imperva at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in the business. Parametric Portfolio Associates LLC increased its position in shares of Imperva by 5.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 11,614 shares of the software maker’s stock valued at $556,000 after purchasing an additional 581 shares during the last quarter. New York State Common Retirement Fund grew its position in shares of Imperva by 3.4% in the 3rd quarter. New York State Common Retirement Fund now owns 37,000 shares of the software maker’s stock valued at $1,606,000 after buying an additional 1,200 shares during the last quarter. American International Group Inc. grew its position in shares of Imperva by 8.1% in the 3rd quarter. American International Group Inc. now owns 22,454 shares of the software maker’s stock valued at $975,000 after buying an additional 1,679 shares during the last quarter. Principal Financial Group Inc. grew its position in shares of Imperva by 51.7% in the 3rd quarter. Principal Financial Group Inc. now owns 7,067 shares of the software maker’s stock valued at $307,000 after buying an additional 2,409 shares during the last quarter. Finally, UBS Asset Management Americas Inc. grew its position in shares of Imperva by 21.4% in the 4th quarter. UBS Asset Management Americas Inc. now owns 15,301 shares of the software maker’s stock valued at $607,000 after buying an additional 2,700 shares during the last quarter.
In related news, Director Anthony J. Bettencourt sold 66,037 shares of the stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total transaction of $3,102,418.26. Following the completion of the sale, the director now owns 66,037 shares in the company, valued at approximately $3,102,418.26. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CRO Michael D. Mooney sold 24,454 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the sale, the executive now owns 24,454 shares of the company’s stock, valued at approximately $1,153,739.72. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.
Shares of Imperva stock opened at $45.80 on Thursday. The firm has a market cap of $1,595.86, a price-to-earnings ratio of 67.35 and a beta of 1.65. Imperva Inc has a 52 week low of $37.17 and a 52 week high of $52.40.
Imperva (NASDAQ:IMPV) last issued its quarterly earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.27 by $0.13. The firm had revenue of $91.10 million during the quarter, compared to analysts’ expectations of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.28%. Imperva’s quarterly revenue was up 16.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.32 EPS. research analysts expect that Imperva Inc will post -0.17 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “HBK Investments L P Acquires New Stake in Imperva Inc (IMPV)” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/3288953/hbk-investments-l-p-acquires-new-stake-in-imperva-inc-impv.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.